<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-E3LMJGEN</identifier><date>2007</date><creator>Peterlin-Mašič, Lucija</creator><creator>Reven, Sebastjan</creator><relation>documents/znanstveni_clanki/farmacevtski_vestnik/html/urn_nbn_si_doc-e3lmjgen.html</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/pdf/urn_nbn_si_doc-e3lmjgen.pdf</relation><relation>documents/znanstveni_clanki/farmacevtski_vestnik/txt/urn_nbn_si_doc-e3lmjgen.txt</relation><format format_type="issue">3</format><format format_type="volume">58</format><format format_type="main">7 strani</format><format format_type="type">article</format><format format_type="extent">str. 79-85</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">2195313</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-E3LMJGEN</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">Alzeheimerjeva bolezen</subject><subject language_type_id="eng">drug</subject><subject language_type_id="slv">zdravila</subject><title>Alzheimerjeva bolezen: nova spoznanja in učinkovine</title></Record>